Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

TakedaFirst wave of new molecular entities has potential to generate 14 approvals

From: Regulatory

BeiGene bags FDA approval for first product Brukinsa in lymphoma

BeigeneAlso the first approval for a Chinese-developed cancer drug in US

From: Regulatory

Amarin wins FDA advisory nod for Vascepa cardiovascular expansion

VascepaApproval likely for fish-oil derived drug following speedy review

From: Regulatory

Shionogi scores FDA approval for new cUTI antibiotic

ShionogiPivotal new treatment for adults with complicated urinary tract infection

Articles

Pharmaceutical Market Europe - November 2019

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

Increased discount leads NICE to reverse positon on Clovis cancer drug

Ovarian cancer drug Rubraca now recommended for use within the Cancer Drugs Fund

Clovis

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

The end of pharma

Some parts of our industry may go the way of the kitchen display cabinet and the word processor

darwins medicine

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...

Infographics